Single-ascending Dose Study of HEC-151 Injection

NCT07376200 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult Male

Interventions

DRUG: HEC-151 Injection
DRUG: Degludec insulin
DRUG: Placebo

Sponsor

Sunshine Lake Pharma Co., Ltd.